Anupam Rasayan rises after Q4 PAT climbs 44% YoY to Rs 45 cr

Image
Last Updated : May 26 2025 | 11:31 AM IST

Anupam Rasayan India rose 2.41% to Rs 687.60 after the company's consolidated net profit surged 44.19% to Rs 44.57 crore on a 24.72% jump in revenue from operations to Rs 500.16 crore in Q4 FY25 over Q4 FY24.

Profit before tax stood at Rs 88.12 crore in Q4 FY25, registering the growth of 52.16%, compared with Rs 57.91 crore posted in the corresponding quarter last year.

EBITDA (including other income) was at Rs 150 crore in Q4 FY25 as compared to Rs 104.7 crore in Q4 FY24, up 43%, and this would translate into 30% EBITDA margin in this quarter.

Total expenses rose 17.58% year on year to Rs 417.58 crore during the quarter. cost of materials consumed stood at Rs 282.97 crore (up 119.61% YoY), while employee benefits expense was at Rs 18.41 crore (up 8.35% YoY) during the period under review.

On a full-year basis, the company's consolidated net profit fell 27.41% to Rs 93.35 crore on 2.58% decrease in revenue to Rs 1,436.97 crore in FY25 over FY24.

Anand Desai, managing director of Anupam Rasayan, commented, Consolidated revenue for the quarter Q4 FY25 stood at Rs 506 crore registering a growth of 22% YoY and 31% QoQ. Consolidated revenue for the full year FY25 stood at Rs 1,448 crore registering a degrowth of 4% YoY. This performance was supported by growth in pharma and polymer coupled with strong performance from Tanfac. Margins have remained consistent this quarter, reflecting our focus on operational efficiency and a favorable product mix.

While H1 FY25 was subdued due to weak macro conditions, I am pleased to share that H2 has shown clear signs of recovery particularly in Q4 FY25 where we have seen meaningful improvement with sales increasing both yearon-year and sequentially. We remain confident in our ability to return to the historical growth rates achieved prior to the recent slowdown.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science-related specialty chemicals, comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigments and dyes and polymer additives.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 26 2025 | 11:11 AM IST

Next Story